Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy

Federico Raviglione, Giorgio Conte, Daniele Ghezzi, Cecilia Parazzini, Andrea Righini, Raffaella Vergaro, Andrea Legati, Luigina Spaccini, Serena Gasperini, Barbara Garavaglia, Massimo Mastrangelo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The FARS2 gene encodes the mitochondrial phenylalanyl-tRNA synthetase and is implicated in autosomal recessive combined oxidative phosphorylation deficiency 14, a clinical condition characterized by infantile onset epilepsy and encephalopathy. Mutations in FARS2 have been reported in only few patients, but a detailed description of seizures, electroencephalographic patterns, magnetic resonance imaging findings, and long-term follow-up is still needed. We provide a clinical report of a child with FARS2-related disease manifesting drug-resistant infantile spasms associated with focal seizures. By comparative genomic hybridization analysis we identified a heterozygous microdeletion in the short arm of chromosome 6, inherited from the mother, that encompasses the first coding exon of FARS2. By sequencing of the FARS2 gene we identified a variant c.1156C>G; p.(R386G), inherited from the father. By using standard spectrophotometric techniques in skin fibroblasts, we found a combined abnormality of complexes I and IV of the mitochondrial respiratory chain. The main clinical features of the patient included axial hypotonia, mild distal hypertonia, and psychomotor delay. The magnetic resonance imaging showed microcephaly, frontal cerebral atrophy, and signal changes of dentate nuclei. At the age of 3 years and 6 months, the patient was still under treatment with vigabatrin and he has been seizure free for the last 23 months.

Original languageEnglish
Pages (from-to)3004-3007
Number of pages4
JournalAmerican Journal of Medical Genetics, Part A
Volume170
Issue number11
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Brain Diseases
Epilepsy
Seizures
Mutation
Phenylalanine-tRNA Ligase
Magnetic Resonance Imaging
Vigabatrin
Infantile Spasms
Cerebellar Nuclei
Mitochondrial Diseases
Microcephaly
Chromosomes, Human, Pair 6
Muscle Hypotonia
Comparative Genomic Hybridization
Mitochondrial Genes
Electron Transport
Fathers
Atrophy
Exons
Fibroblasts

Keywords

  • encephalopathy
  • epilepsy
  • FARS2
  • mitochondrial diseases

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Raviglione, F., Conte, G., Ghezzi, D., Parazzini, C., Righini, A., Vergaro, R., ... Mastrangelo, M. (2016). Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy. American Journal of Medical Genetics, Part A, 170(11), 3004-3007. https://doi.org/10.1002/ajmg.a.37836

Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy. / Raviglione, Federico; Conte, Giorgio; Ghezzi, Daniele; Parazzini, Cecilia; Righini, Andrea; Vergaro, Raffaella; Legati, Andrea; Spaccini, Luigina; Gasperini, Serena; Garavaglia, Barbara; Mastrangelo, Massimo.

In: American Journal of Medical Genetics, Part A, Vol. 170, No. 11, 01.11.2016, p. 3004-3007.

Research output: Contribution to journalArticle

Raviglione, F, Conte, G, Ghezzi, D, Parazzini, C, Righini, A, Vergaro, R, Legati, A, Spaccini, L, Gasperini, S, Garavaglia, B & Mastrangelo, M 2016, 'Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy', American Journal of Medical Genetics, Part A, vol. 170, no. 11, pp. 3004-3007. https://doi.org/10.1002/ajmg.a.37836
Raviglione, Federico ; Conte, Giorgio ; Ghezzi, Daniele ; Parazzini, Cecilia ; Righini, Andrea ; Vergaro, Raffaella ; Legati, Andrea ; Spaccini, Luigina ; Gasperini, Serena ; Garavaglia, Barbara ; Mastrangelo, Massimo. / Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy. In: American Journal of Medical Genetics, Part A. 2016 ; Vol. 170, No. 11. pp. 3004-3007.
@article{9516e53c7e7a493390585bee2a12f002,
title = "Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy",
abstract = "The FARS2 gene encodes the mitochondrial phenylalanyl-tRNA synthetase and is implicated in autosomal recessive combined oxidative phosphorylation deficiency 14, a clinical condition characterized by infantile onset epilepsy and encephalopathy. Mutations in FARS2 have been reported in only few patients, but a detailed description of seizures, electroencephalographic patterns, magnetic resonance imaging findings, and long-term follow-up is still needed. We provide a clinical report of a child with FARS2-related disease manifesting drug-resistant infantile spasms associated with focal seizures. By comparative genomic hybridization analysis we identified a heterozygous microdeletion in the short arm of chromosome 6, inherited from the mother, that encompasses the first coding exon of FARS2. By sequencing of the FARS2 gene we identified a variant c.1156C>G; p.(R386G), inherited from the father. By using standard spectrophotometric techniques in skin fibroblasts, we found a combined abnormality of complexes I and IV of the mitochondrial respiratory chain. The main clinical features of the patient included axial hypotonia, mild distal hypertonia, and psychomotor delay. The magnetic resonance imaging showed microcephaly, frontal cerebral atrophy, and signal changes of dentate nuclei. At the age of 3 years and 6 months, the patient was still under treatment with vigabatrin and he has been seizure free for the last 23 months.",
keywords = "encephalopathy, epilepsy, FARS2, mitochondrial diseases",
author = "Federico Raviglione and Giorgio Conte and Daniele Ghezzi and Cecilia Parazzini and Andrea Righini and Raffaella Vergaro and Andrea Legati and Luigina Spaccini and Serena Gasperini and Barbara Garavaglia and Massimo Mastrangelo",
year = "2016",
month = "11",
day = "1",
doi = "10.1002/ajmg.a.37836",
language = "English",
volume = "170",
pages = "3004--3007",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy

AU - Raviglione, Federico

AU - Conte, Giorgio

AU - Ghezzi, Daniele

AU - Parazzini, Cecilia

AU - Righini, Andrea

AU - Vergaro, Raffaella

AU - Legati, Andrea

AU - Spaccini, Luigina

AU - Gasperini, Serena

AU - Garavaglia, Barbara

AU - Mastrangelo, Massimo

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The FARS2 gene encodes the mitochondrial phenylalanyl-tRNA synthetase and is implicated in autosomal recessive combined oxidative phosphorylation deficiency 14, a clinical condition characterized by infantile onset epilepsy and encephalopathy. Mutations in FARS2 have been reported in only few patients, but a detailed description of seizures, electroencephalographic patterns, magnetic resonance imaging findings, and long-term follow-up is still needed. We provide a clinical report of a child with FARS2-related disease manifesting drug-resistant infantile spasms associated with focal seizures. By comparative genomic hybridization analysis we identified a heterozygous microdeletion in the short arm of chromosome 6, inherited from the mother, that encompasses the first coding exon of FARS2. By sequencing of the FARS2 gene we identified a variant c.1156C>G; p.(R386G), inherited from the father. By using standard spectrophotometric techniques in skin fibroblasts, we found a combined abnormality of complexes I and IV of the mitochondrial respiratory chain. The main clinical features of the patient included axial hypotonia, mild distal hypertonia, and psychomotor delay. The magnetic resonance imaging showed microcephaly, frontal cerebral atrophy, and signal changes of dentate nuclei. At the age of 3 years and 6 months, the patient was still under treatment with vigabatrin and he has been seizure free for the last 23 months.

AB - The FARS2 gene encodes the mitochondrial phenylalanyl-tRNA synthetase and is implicated in autosomal recessive combined oxidative phosphorylation deficiency 14, a clinical condition characterized by infantile onset epilepsy and encephalopathy. Mutations in FARS2 have been reported in only few patients, but a detailed description of seizures, electroencephalographic patterns, magnetic resonance imaging findings, and long-term follow-up is still needed. We provide a clinical report of a child with FARS2-related disease manifesting drug-resistant infantile spasms associated with focal seizures. By comparative genomic hybridization analysis we identified a heterozygous microdeletion in the short arm of chromosome 6, inherited from the mother, that encompasses the first coding exon of FARS2. By sequencing of the FARS2 gene we identified a variant c.1156C>G; p.(R386G), inherited from the father. By using standard spectrophotometric techniques in skin fibroblasts, we found a combined abnormality of complexes I and IV of the mitochondrial respiratory chain. The main clinical features of the patient included axial hypotonia, mild distal hypertonia, and psychomotor delay. The magnetic resonance imaging showed microcephaly, frontal cerebral atrophy, and signal changes of dentate nuclei. At the age of 3 years and 6 months, the patient was still under treatment with vigabatrin and he has been seizure free for the last 23 months.

KW - encephalopathy

KW - epilepsy

KW - FARS2

KW - mitochondrial diseases

UR - http://www.scopus.com/inward/record.url?scp=84991489226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991489226&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.37836

DO - 10.1002/ajmg.a.37836

M3 - Article

AN - SCOPUS:84991489226

VL - 170

SP - 3004

EP - 3007

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 11

ER -